Aligning with the World Health Organization’s (WHO) theme for the World Health Day (WHD) 2025, “Healthy Beginnings, Hopeful Futures,” QNET, a global direct-selling company focusing on wellness and lifestyle, has reaffirmed its dedication to enhancing maternal and neonatal health in developing markets.
The company highlighted its range of scientifically supported wellness and nutritional products as a key component in addressing critical health challenges.
QNET’s initiative comes at a time when maternal and newborn mortality rates remain alarmingly high, particularly in lower- and middle-income countries. According to WHO data, in 2020, 287,000 women died from pregnancy and childbirth complications, with 95% of these deaths occurring in developing regions. UNICEF reported that in 2022, 2.3 million newborns died within their first 28 days of life, accounting for nearly half of all child mortality under five globally. Many of these deaths are attributed to preventable causes, including hemorrhages, hypertensive disorders, infections, and complications of premature birth, all of which are significantly impacted by access to proper nutrition and safe water.
“The foundation of a healthy society starts with the well-being of mothers and their newborns,” stated Biram Fall, Regional General Manager for QNET Sub-Saharan Africa. “At QNET, we are focused on scientifically driven wellness products that support women’s health at this most critical life stage.”
QNET’s product offerings include EDG3 Plus, a glutathione precursor blend designed to improve cellular repair and immune function, both crucial for maternal health. Glutathione deficiency is linked to pregnancy complications, making supplementation a potentially vital intervention. Additionally, the HomePure Nova, a seven-stage water filtration system, addresses the issue of unsafe drinking water, a major cause of diarrheal diseases and maternal and infant morbidity, particularly in countries like Nigeria.
Akeem Ajisafe, Managing Director of Transblue Limited, QNET’s Nigerian partner, emphasized the local impact: “In Nigeria, where we continue to face high maternal and neonatal mortality rates, QNET’s products offer an accessible, science-backed complement to traditional healthcare.”
World Bank data indicates that Nigeria had a maternal mortality rate of 512 deaths per 100,000 live births in 2020.
QNET’s strategy reflects a market-driven approach to addressing public health gaps, leveraging its distribution model to bring wellness products to underserved communities and promote preventive health. This initiative underscores the growing importance of public-private partnerships in strengthening overstretched health systems in sub-Saharan Africa. As governments face increasing pressure to meet Sustainable Development Goal 3, initiatives like QNET’s demonstrate the potential role of corporations in achieving health equity.